Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arsenic Trioxide”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Testing effectiveness (Phase 2)Study completedNCT00551460
What this trial is testing

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)UnknownNCT04689815
What this trial is testing

Oral Arsenic Trioxide for NPM1-mutated AML

Who this might be right for
NPMc+ AML
The University of Hong Kong 50
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006021
What this trial is testing

Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Miami 22
Testing effectiveness (Phase 2)Study completedNCT00250042
What this trial is testing

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Who this might be right for
Leukemia, OtherCancer
New Mexico Cancer Research Alliance 6
Early research (Phase 1)Study completedNCT00124605
What this trial is testing

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Testing effectiveness (Phase 2)Ended earlyNCT00803530
What this trial is testing

Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Fondazione Italiana Sindromi Mielodisplastiche-ETS 55
Early research (Phase 1)Study completedNCT00449137
What this trial is testing

Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment

Who this might be right for
Colorectal Cancer
University of Miami 13
Testing effectiveness (Phase 2)Ended earlyNCT00017069
What this trial is testing

Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Testing effectiveness (Phase 2)WithdrawnNCT00670150
What this trial is testing

New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
University of Southern California
Early research (Phase 1)Study completedNCT00671697
What this trial is testing

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
Washington University School of Medicine 13
Testing effectiveness (Phase 2)Study completedNCT00201695
What this trial is testing

Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ohio State University Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00004149
What this trial is testing

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 37
Testing effectiveness (Phase 2)Looking for participantsNCT04687176
What this trial is testing

Frontline Oral Arsenic Trioxide for APL

Who this might be right for
Acute Promyelocytic Leukemia
The University of Hong Kong 100
Testing effectiveness (Phase 2)Ended earlyNCT00017433
What this trial is testing

Arsenic Trioxide in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
CTI BioPharma
Large-scale testing (Phase 3)Study completedNCT00003934
What this trial is testing

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Childhood Acute Promyelocytic Leukemia (M3)+2 more
National Cancer Institute (NCI) 420
Large-scale testing (Phase 3)Not Yet RecruitingNCT07296445
What this trial is testing

A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

Who this might be right for
Acute Promyelocytic Leukemia (APL)Acute Promyelocytic LeukaemiaAcute Promyelocytic Leukemia With PML-RARA+6 more
SDK Therapeutics, Inc. 120
Large-scale testing (Phase 3)Ended earlyNCT00513305
What this trial is testing

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Cephalon 67
Load More Results